Samuel D. Waksal (born September 8, 1947) is the founder and former CEO of the biopharmaceutical company ImClone Systems. He is also the founder of Kadmon Pharmaceuticals, which was financed with private capital and commenced operations in …

Oct 30, 2024 · Sam Waksal was sentenced to seven years and three months in prison and ordered to pay over $4 million in fines and back taxes. He was released on February 9, 2009, but faced a lifetime ban from serving as an officer or director of any public company.

Convicted: October 15, 2002 of securities fraud, bank fraud, obstruction of justice, and perjury. Known for his networking skills as much as for his scientific expertise, immunologist...

Jun 10, 2003 · NEW YORK (CNN/Money) - Ex-ImClone Systems CEO Samuel Waksal, who once dreamed of developing a blockbuster cancer drug, was sentenced to just over seven years in prison and ordered to pay $4.3...

Oct 31, 2024 · According to Forbes, in June 2003 Waksal was sentenced to 87 months in prison and was ordered to pay a $3 million fine. He was out in 2009, the same year "ImClone was sold to Eli Lilly for $6.5 billion and five years after Erbitux eventually gained FDA approval," per CNBC. So, where is he now? Here's what we know. Where is Sam Waksal now?

ImClone's founder, Samuel D. Waksal, was arrested in 2002 on insider trading charges for instructing friends and family to sell their stock, and attempting to sell his own. His daughter, Aliza Waksal, sold $2.5 million in shares on December 27.

Jun 10, 2003 · Today, the former ImClone Systems chief executive, Samuel D. Waksal Samuel D. Waksal , was sentenced to 87 months and a $3 million fine for charges of insider trading and fraud related to his...

Jun 11, 2003 · A federal judge yesterday sentenced Samuel D. Waksal, the founder and former chief executive of ImClone Systems, to more than seven years in prison for securities fraud, perjury and other...

Mar 11, 2003 · Securities and Exchange Commission v. Samuel D. Waksal. NEW YORK - The Securities and Exchange Commission today filed additional charges against the former CEO of ImClone Systems Inc. Samuel Waksal, for illegal insider trading and failure to publicly disclose securities transactions.

The Commission charges Sam Waksal, co-founder and former chief executive officer of ImClone Systems, Inc. ("ImClone"), with violating the federal securities laws in late December 2001 by actual and attempted insider trading in ImClone stock, and by illegally tipping his father Jack Waksal about disappointing, confidential developments at ImClone.